MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace® RNS® System, a treatment for adults with partial onset seizures...
Nov. 14, 2013 – This month, the Epilepsy Foundation and Lundbeck joined together in a nationwide effort to bring information about managing seizures to people living with epilepsy and their families. At the center of the initiative is a new...
Welcome to November -- National Epilepsy Awareness Month! This month we are celebrating the stories of people who have been able to defy their seizures and focus on reaching their full life potential. Today, November 1st, is Lennox-Gastaut...
By Warren Lammert, Chair, Epilepsy Foundation Coach Jerry Kill of the University of Minnesota had a seizure on the sidelines of the Western Illinois game on Saturday afternoon. Seizures are scary and unpredictable but are also part of the routine...
Trokendi XR Helps Partial Onset and Seizures Associated with Lennox-Gastaut Syndrome The Food & Drug Administration has issued final approval for Trokendi XR, an extended-release oral formulation of topiramate for treatment of epilepsy....

Pages